Patient Guide: A Study of the Safety and Efficacy of Prime Editing (PM359) in Participants With p47phox Autosomal Recessive Chronic Granulomatous Disease (CGD )

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 5 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT06559176
Status: ACTIVE_NOT_RECRUITING
Condition: Chronic Granulomatous Disease, Granulomatous Disease, Chronic
Phase: PHASE1, PHASE2

Find a Study Location Near You

This study is available at 5 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Los Angeles, California
  • Bethesda, Maryland
  • Nashville, Tennessee
  • • And 2 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily